CD209 and colonic neoplasm: IHC for DC-SIGN and DC-SIGNR was performed using 98 colon cancer tissues for DC-SIGN and 20 cancer tissues for DC-SIGNR, with the staining intensity determined by a pathologist who was blinded to the relevant clinical information.